Success Stories: EB-1A Approved for Scientist in New York in the Field of Pharmaceutical Sciences
Client’s Testimonial:
I highly appreciate the outstanding work and help provided by North America Immigration Law group to me during my I-140 petition. They have very good understanding of the case and even easily understood my research and full profile to make the petition. There response before committed time is really appreciable. I found that the case taken by them is a big assurance that it is going to be approved. My EB1A- I-140 got approved very quickly even the day after the premium processing application was received without any RFE or difficulty. I highly recommend Chen Immigration Team for green card petitions. Thanks a lot for their big help.I highly appreciate the outstanding work and help provided by North America Immigration Law group to me during my I-140 petition. They have very good understanding of the case and even easily understood my research and full profile to make the petition. There response before committed time is really appreciable. I found that the case taken by them is a big assurance that it is going to be approved. My EB1A- I-140 got approved very quickly even the day after the premium processing application was received without any RFE or difficulty. I highly recommend Chen Immigration Team for green card petitions. Thanks a lot for their big help.
On October 17th, 2014, We Received Another EB1-A (Alien of Extraordinary Ability) Approval for a Scientist in the Field of Pharmaceutical Sciences (Approval Notice)
Position at the Time of Case Filing: Scientist
Country of Origin: India
State of Residence at the Time of Filing: New York
Approval Notice Date: October 17th, 2014
Processing Time: 18 Days (4 Days After Premium Processing Requested)
For this case we were granted the opportunity to work with a pharmaceutical scientist from India, whose research focused on the design, synthesis, and characterization of inhibitors involved in multi-drug resistance to anticancer therapeutics. He had published a prolific 25 peer-reviewed scientific articles, as well as given numerous presentations at conferences both national and international; furthermore, his work had been cited no fewer than 279 times at case filing, by independent and leading researchers worldwide working at prestigious institutions and for prominent organizations, indicating its major significance. He had also reviewed 13 manuscripts for distinctive, internationally-circulated journals. An independent recommender affirmed our client’s superior expertise: “His research specifically targets the problem of multi-drug resistance (MDR), a process…by which anticancer drugs are eliminated from cancer cells in cancer patients, rendering cancer chemotherapy ineffective…I can recommend [Client] as a very successful pharmaceutical scientist who is an eminent investigator in the field of multidrug resistance, with the goal of developing new strategies for successfully treating cancer.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of Pharmaceutical Sciences, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in eighteen days.